Table 2 Medications used by participants during study period—comparison between the two study groups (2866 participants)
From: HbA1C variability among type 2 diabetic patients: a retrospective cohort study
Variable | HbA1C variability (N = 632) | No HbA1C variability (N = 2234) | p value |
|---|---|---|---|
Insulin: (N = 1217) | 71.2% (450) | 34.3% (767) | < 0.001 |
Diabetes oral treatment: (N = 2847) | 100% (632) | 99.1% (2215) | 0.012 |
Statins: (N = 2689) | 94.6% (598) | 93.6% (2091) | 0.346 |
ARB’s and ACE inhibitors: (N = 2556) | 93.5% (591) | 88% (1965) | < 0.001 |